Lin Wei-Chen, Chang Chen-Wang, Chen Ming-Jen, Wang Horng-Yuan
Division of Gastroenterology, Department of Internal Medicine, Mackay Memorial Hospital, Taipei, Taiwan.
Mackay Junior College of Medicine, Nursing and Management, Taipei, Taiwan.
J Med Ultrasound. 2023 Jan 19;31(2):86-91. doi: 10.4103/jmu.jmu_84_22. eCollection 2023 Apr-Jun.
New and efficacious medical therapies have become available that have greatly enhanced clinicians' ability to manage inflammatory bowel diseases (IBDs). IBD activity should be assessed regularly in scheduled examinations as the part of a treat-to-target strategy for IBD care. The gold-standard approach to investigating IBD is colonoscopy, but this is an invasive procedure. Intestinal ultrasound (IUS) has played a crucial role in recent years regarding the assessment of IBD activity because it is noninvasive, safe, reproducible, and inexpensive. IUS findings could inform changes in therapeutic interventions for IBDs; this would necessitate fewer endoscopies and enable faster decision-making processes. Furthermore, patients are accepting and tolerant of IUS examinations. This review outlines the current evidence and gives indication regarding the use of IUS in the management of IBDs.
新的有效医学疗法已经出现，极大地提高了临床医生管理炎症性肠病（IBD）的能力。作为IBD治疗达标策略的一部分，应在定期检查中定期评估IBD活动。调查IBD的金标准方法是结肠镜检查，但这是一种侵入性操作。近年来，肠道超声（IUS）在评估IBD活动方面发挥了关键作用，因为它是非侵入性的、安全的、可重复的且成本低廉。IUS检查结果可为IBD治疗干预措施的改变提供依据；这将减少内镜检查的次数，并加快决策过程。此外，患者对IUS检查接受度高且耐受性好。本综述概述了当前证据，并就IUS在IBD管理中的应用给出了指导意见。
